Voucher Program Extended for Arthritis Drug

JANUARY 01, 2005

The Trial Script voucher program for Rheumatrex Dose Pack (methotrexate sodium tablets) has been extended to August 2005. Rheumatrex, manufactured by STADA Pharmaceuticals, Inc, is a once-weekly disease-modifying antirheumatic drug for rheumatoid arthritis.

In the voucher program, patients receive a free 1-month trial supply of Rheumatrex in any weekly dosage available (5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg). Physicians affix the voucher to the back of the prescription form. The patients activate the voucher by calling a toll-free number. Transactions are electronically processed through drug utilization programs, which may detect potential drug interactions.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.